e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Asthma and allergy: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
J. Cho (Seoul, Republic of Korea)
Source:
International Congress 2017 – Asthma and allergy: from the bench to the bedside
Session:
Asthma and allergy: from the bench to the bedside
Session type:
Poster Discussion
Number:
3543
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cho (Seoul, Republic of Korea). Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis. 3543
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Gender differences in eosinophilic airway inflammation in allergic and non-allergic asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
Airway remodelling is present in children with asthma regardless of eosinophilic inflammation
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Association between eosinophilic airway inflammation and T-cells response in children with bronchial asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Cinical assessment of asthma severity partially corresponds to eosinophilic airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002
Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020
Year: 2020
Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020
Year: 2020
Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Year: 2020
Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Mepolizumab improves small airway function in severe eosinophilic asthma
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
Role of neutrophils in airway inflammation in children with chronic bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept